US › Healthcare

Curanex Pharmaceuticals Inc Common Stock (CURX)

US · Healthcare · Biotechnology

$4.62-4.35%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.3M

EPS

$-0.03

Key statistics

Market cap

$7.7M

Forward P/E

0.0

P/B

1.47

Book value

$3.38

EPS (TTM)

$-7.80

52-week high

$16.93

52-week low

$3.58

50-day MA

$4.59

200-day MA

$6.32

Shareholding

Insiders

61.35%

Institutions

1.06%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.30%
Renaissance Technologies Corp	0.17%
Virtu Financial LLC	0.16%
Geode Capital Management, LLC	0.12%
Jane Street Group LLC	0.10%
Two Sigma Investments LLC	0.09%
Susquehanna International Group, LLP	0.05%
Ground Swell Capital, LLC	0.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Curanex Pharmaceuticals Inc Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.